Cranbiotic400 mg

Cranbiotic is a herbal/nutritional supplement derived from cranberry fruit extract. It is used based on the following evidence:

• Guideline/evidence-supported use: As an adjunct for the prevention of recurrent urinary tract infections (UTIs), particularly in women with a history of recurrent uncomplicated UTIs. Clinical evidence is moderate and mixed across studies; some trials show a modest reduction (roughly 25-30%) in recurrence risk, while others show no significant benefit, so it should be regarded as a supportive preventive measure rather than a guaranteed benefit.
• Adjunct use only: Cranbiotic is intended for prevention, not treatment, of UTIs. It is not a substitute for antibiotics in an active or confirmed UTI.
• Not FDA-approved as a drug: Cranbiotic is marketed as a dietary/herbal supplement, not as an FDA-approved prescription medicine; claims are based on limited evidence permitted under supplement labeling regulations rather than a formal drug indication.

Each dosage unit (capsule/tablet/syrup) contains standardized Cranberry [Vaccinium macrocarpon] fruit extract, typically standardized to a defined proanthocyanidin (PAC) content. Strength varies by brand and formulation (e.g., 300-500 mg extract per capsule, or 300 mg/5 mL syrup). Refer to the specific product label for exact strength and excipients.

Cranbiotic is derived from the fruit of the cranberry plant (Vaccinium macrocarpon), a shrub native to North America. Cranberry fruit contains proanthocyanidins (PACs), particularly type-A proanthocyanidins, which are believed to inhibit the adhesion of certain bacteria (notably E. coli) to the urinary tract lining, thereby reducing the likelihood of bacterial colonization and recurrent infection.

Cranbiotic is available in various forms including capsules, tablets, and oral syrup, and is commonly used as a dietary supplement for urinary tract health rather than as a conventional pharmaceutical.

Herbal/nutritional supplement - urinary tract health agent (Cranbiotic)

Mechanism of Action

Cranberry [Vaccinium macrocarpon] contains proanthocyanidins (PACs), particularly A-type PACs, which are thought to interfere with the ability of fimbriated bacteria (especially uropathogenic Escherichia coli) to adhere to uroepithelial cells lining the bladder and urinary tract. By reducing bacterial adhesion, Cranberry [Vaccinium macrocarpon] may lower the likelihood of bacterial colonization and subsequent infection, rather than exerting a direct antibacterial (killing) effect.

Pharmacokinetics

PACs and other cranberry polyphenols undergo partial absorption and metabolism; a portion is excreted in urine, which is consistent with the proposed local anti-adhesive mechanism in the urinary tract. Detailed pharmacokinetic data (e.g., precise bioavailability, half-life) are not well characterized due to the product's classification as a dietary supplement rather than a regulated drug.

Cranbiotic can be taken orally with or without food. Capsules/tablets should be swallowed with a glass of water; syrup formulations should be shaken well before use and measured using the provided measuring cup or spoon. Maintaining good hydration while using Cranbiotic is recommended to support the intended urinary tract benefit.

Warfarin: Case reports describe a clinically significant interaction in which concomitant use of cranberry products with warfarin potentiated the anticoagulant effect and increased INR (International Normalized Ratio), with some cases associated with bleeding. The proposed mechanism involves inhibition of warfarin metabolism (CYP2C9 pathway). Patients on warfarin who wish to use Cranbiotic should inform their physician; closer INR monitoring is advised if concurrent use cannot be avoided.

Theoretical interactions with other drugs metabolized via cytochrome P450 enzymes have been proposed but are not well-established clinically; caution and physician consultation are advised when combining Cranbiotic with other prescription medications, particularly anticoagulants/antiplatelet agents.

Cranbiotic is generally well tolerated when taken at recommended doses. The most commonly reported side effects are gastrointestinal and include:

• Mild stomach upset
• Diarrhea
• Nausea

These effects are more likely with concentrated extracts or higher-than-recommended doses. Rare hypersensitivity reactions (e.g., skin rash) may occur in sensitive individuals.

Cranbiotic has a long history of use as a dietary fruit product and is generally considered to carry relatively low risk when consumed in ordinary food amounts during pregnancy and breastfeeding. However, for concentrated supplement forms, safety data are limited. As a conservative approach, Cranbiotic supplement products should be used during pregnancy or lactation only if clearly needed, and a physician should be consulted before use to weigh potential benefit against any uncertain risk.

• Not a treatment for active UTI: Cranbiotic is intended for prevention only. It is not a substitute for antibiotic therapy in a confirmed or symptomatic urinary tract infection; delaying appropriate antibiotic treatment in favor of Cranbiotic could allow infection to worsen.
• Kidney stone risk: Cranberry contains oxalate, which may theoretically contribute to oxalate-containing kidney stone formation in susceptible individuals (e.g., those with a personal history of calcium-oxalate stones). Such patients should use Cranbiotic with caution and under physician guidance.
• Hypersensitivity: See Contraindications.
• Anticoagulant use: See Interactions (warfarin).
• Diabetic patients: Some cranberry juice/syrup products contain added sugars; patients with diabetes should check product labels and prefer sugar-free formulations where available.

Excessive intake of Cranbiotic may increase the likelihood of gastrointestinal side effects such as stomach upset and diarrhea, and, in very high or prolonged supplemental doses, could theoretically increase the risk of oxalate kidney stone formation in susceptible individuals. There is no established specific antidote. If a large overdose is suspected or the person develops severe symptoms (e.g., persistent vomiting, severe abdominal pain, signs of kidney stone such as severe flank pain or blood in urine), seek immediate medical attention or contact a poison control center/emergency services.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pediatric Use

Safety and efficacy of standardized Cranbiotic extract products for UTI prevention in children have not been well established through controlled pediatric trials. Use in children should only be under the guidance of a pediatrician, generally reserved for children with recurrent UTIs where dietary measures are being considered as an adjunct, and dosing should follow product-specific pediatric labeling if available.

Elderly Use

No specific dose adjustment is generally required for elderly patients; however, elderly individuals, especially those on warfarin or with reduced renal function or a history of kidney stones, should use Cranbiotic with caution and physician oversight (see Interactions and Precautions).

Renal Impairment

Patients with a history of kidney stones or significant renal impairment should consult a physician before using Cranbiotic due to the oxalate content (see Precautions and Warnings).

Hepatic Impairment

No well-established dose adjustment is required; data are limited, so caution is advised.

Cranbiotic is typically used as an ongoing preventive supplement for individuals prone to recurrent UTIs, rather than for a fixed short-term course. Duration of use should be individualized based on the frequency of recurrent infections and physician advice; periodic reassessment of continued need is recommended, especially given the moderate/mixed strength of supporting evidence.

Herbal supplement / Nutraceutical - Urinary tract health agent (Cranberry [Vaccinium macrocarpon])

Cranberry [Vaccinium macrocarpon] contains type-A proanthocyanidins (PACs) believed to inhibit adhesion of fimbriated uropathogenic bacteria (particularly E. coli) to the urothelium lining the bladder and urinary tract, thereby reducing bacterial colonization rather than acting as a direct antimicrobial agent.

Safety and efficacy of standardized Cranbiotic extract/supplement products have not been well established in children through robust controlled trials. Where used for recurrent UTI prevention in children, it should be under pediatrician supervision, following age/product-appropriate dosing on the specific label, and is not a substitute for medical evaluation of recurrent pediatric UTIs, which often require investigation for underlying anatomical or functional causes.